Evidence map›Paper›PMID 24025583›Full record

ArticleEndocrine-related cancer2013

The thyroid cancer PAX8-PPARG fusion protein activates Wnt/TCF-responsive cells that have a transformed phenotype.

Dang Vu-Phan, Vladimir Grachtchouk, Jingcheng Yu, Lesley A Colby, Max S Wicha, Ronald J Koenig

Open access · bronzeAbstract read
In one paragraph

Article in Endocrine-related cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Follicular adenoma of the thyroid with hyalinizing trabecular tumor-like pattern.Virchows Archiv : an international journal of pathology · 2026
    Article
  2. PAX Family, Master Regulator in Cancer.Diagnostics (Basel, Switzerland) · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Coding Molecular Determinants of Thyroid Cancer Development and Progression.Endocrinology and metabolism clinics of North America · 2019
    Review
  7. Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.Clinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Article
  8. Article
  9. Article
  10. Review
  11. Pax-8-PPAR-γ fusion protein in thyroid carcinoma.Nature reviews. Endocrinology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Dang Vu-PhanCellular and Molecular Biology Graduate Program, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, 48109, USA.
Vladimir Grachtchouk
Jingcheng Yu
Lesley A Colby
Max S Wicha
Ronald J Koenig
Diabetes Australia · AUAnn Arbor Center for Independent Living · USUniversity of Michigan–Ann Arbor · USUniversity of Washington · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
Stem Cell Self-Renewal mammary CarcinogenesisR01CA129765 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WICHA, MAX S. · 2008 to 2015
$2.4M
In vivo therapy and mechanisms of PAX8-PPARgamma thyroid cancerR01CA166033 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KOENIG, RONALD JAY · 2013 to 2017
$2.4M
Pax8-PPARgamma regulation of transcription and metabolism in thyroid cancerR01CA151842 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KOENIG, RONALD JAY · 2010 to 2014
$1.6M
NCI NIH HHS R01 CA129765NCI NIH HHS R01CA129765NCI NIH HHS R01 CA151842NCI NIH HHS R01CA151842NCI NIH HHS R01 CA166033NCI NIH HHS R01CA166033NIDDK NIH HHS P30 DK020572NIGMS NIH HHS T32 GM007315NIGMS NIH HHS T32GM007315
6 · The paper itself

Abstract

A chromosomal translocation results in the production of a paired box 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARG) fusion protein (PPFP) in ∼35% of follicular thyroid carcinomas. To examine the role of PPFP in thyroid oncogenesis, the fusion protein was stably expressed in the non-transformed rat thyroid cell line PCCL3. PPFP conferred on PCCL3 cells the ability to invade through Matrigel and to form colonies in anchorage-independent conditions. PPFP also increased the fraction of cells with Wnt/TCF-responsive green fluorescent protein reporter gene expression. This Wnt/TCF-activated population was enriched for colony-forming and invading cells. These actions of PPFP required a functional PPARG DNA binding domain (DBD) within PPFP and were further stimulated by PPARG agonists. These data indicate that PPFP, through its PPARG DBD, induces Wnt/TCF pathway activation in a subpopulation of cells, and these cells have properties of cellular transformation including increased invasiveness and anchorage-independent growth.

Indexed as

AnimalsCell LineCell Line, TumorHumansMiceMice, TransgenicOncogene Proteins, FusionPaired Box Transcription FactorsPhenotypePioglitazonePPAR gammaRatsTCF Transcription FactorsThiazolidinedionesThyroid NeoplasmsWnt ProteinsOncogene Proteins, FusionPaired Box Transcription FactorsPioglitazonePPAR gammaTCF Transcription FactorsThiazolidinedionesWnt ProteinsPPFPTCFthyroid carcinomaWnt

Identifiers

PMID24025583
PMCPMC3839064
OpenAlexW2054531656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.